Daratumumab (dara) as maintenance therapy after autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): results of a phase 2 study-MedSci.cn

Daratumumab (dara) as maintenance therapy after autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): results of a phase 2 study

Borogovac, A; Pichiorri, F; Matous, J; Berdeja, J; Pozhitkov, A; Tandoh, T; Chowdhury, A; Sanchez, J; Palmer, J; Morales, A; Keats, J; Goldsmith, S; Htut, M; Janakiram, M; Nathwani, N; Rosenzweig, M; Krishnan, A

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023; 23 (): S107

科室
- - 订阅+
  - 更多科室
工具
服务